Undressing the Fungal Cell Wall/Cell Membrane - the Antifungal Drug Targets

被引:37
作者
Tada, Rui [1 ]
Latge, Jean-Paul [1 ]
Aimanianda, Vishukumar [1 ]
机构
[1] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France
关键词
Aspergillus fumigatus; Candida albicans; azole; echinocandin; cell wall; polysaccharide; chitin; glucan; mannan; antifungal drugs; ERGOSTEROL BIOSYNTHESIS PATHWAY; LIPOSOMAL AMPHOTERICIN-B; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; CHITIN SYNTHASE; AZOLE RESISTANCE; GLUCAN SYNTHASE; IN-VITRO; PEPTIDOGLYCAN STRUCTURE; INVASIVE ASPERGILLOSIS;
D O I
10.2174/1381612811319200012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Being external, the fungal cell wall plays a crucial role in the fungal life. By covering the underneath cell, it offers mechanical strength and acts as a barrier, thus protecting the fungus from the hostile environment. Chemically, this cell wall is composed of different polysaccharides. Because of their specific composition, the fungal cell wall and its underlying plasma membrane are unique targets for the development of drugs against pathogenic fungal species. The objective of this review is to consolidate the current knowledge on the antifungal drugs targeting the cell wall and plasma membrane, mainly of Aspergillus and Candida species - the most prevalent fungal pathogens, and also to present challenges and questions conditioning the development of new antifungal drugs targeting the cell wall.
引用
收藏
页码:3738 / 3747
页数:10
相关论文
共 123 条
  • [1] TEMPERATURE-INDUCED MODIFICATIONS OF GLYCOSPHINGOLIPIDS IN PLASMA-MEMBRANES OF NEUROSPORA-CRASSA
    AARONSON, LR
    MARTIN, CE
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 735 (02) : 252 - 258
  • [2] Problems and hopes in the development of drugs targeting the fungal cell wall
    Aimanianda, Vishukumar
    Latge, Jean-Paul
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (04) : 359 - 364
  • [3] Cell wall active antifungal compounds produced by the marine fungus Hypoxylon oceanicum LL-15G256 -: III.: Biological properties of 15G256γ
    Albaugh, D
    Albert, G
    Bradford, P
    Cotter, V
    Froyd, J
    Gaughran, J
    Kirsch, DR
    Lai, M
    Rehnig, A
    Sieverding, E
    Silveriman, S
    [J]. JOURNAL OF ANTIBIOTICS, 1998, 51 (03) : 317 - 322
  • [4] Ergosterol biosynthesis pathway in Aspergillus fumigatus
    Alcazar-Fuoli, Laura
    Mellado, Emilia
    Garcia-Effron, Guillermo
    Lopez, Jordi R.
    Grimalt, Joan O.
    Cuenca-Estrella, J. Manuel
    Rodriguez-Tudela, Juan L.
    [J]. STEROIDS, 2008, 73 (03) : 339 - 347
  • [5] Evolution of antifungal-drug resistance: Mechanisms and pathogen fitness
    Anderson, JB
    [J]. NATURE REVIEWS MICROBIOLOGY, 2005, 3 (07) : 547 - 556
  • [6] Posaconazole: A New Antifungal Weapon
    Aperis, Georgios
    Alivanis, Polichronis
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2011, 6 (03) : 204 - 219
  • [7] Establishing in vitro-in vivo correlations for Aspergillus fumigatus:: the challenge of azoles versus echinocandins
    Arendrup, Maiken Cavling
    Perkhofer, Susanne
    Howard, Susan J.
    Garcia-Effron, Guillermo
    Vishukumar, Aimanianda
    Perlin, David
    Lass-Floerl, Cornelia
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) : 3504 - 3511
  • [8] Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence
    Arendrup, Maiken Cavling
    Mavridou, Eleftheria
    Mortensen, Klaus Leth
    Snelders, Eveline
    Frimodt-Moller, Niels
    Khan, Humara
    Melchers, Willem J. G.
    Verweij, Paul E.
    [J]. PLOS ONE, 2010, 5 (04):
  • [9] Armstrong-James D, 2012, CURR OPIN MICROBIOL
  • [10] Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast
    Bagnat, M
    Keränen, S
    Shevchenko, A
    Shevchenko, A
    Simons, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3254 - 3259